Page 79 - GlaxoSmithKline Pharmaceuticals AR 2012

75
2 SHARE CAPITAL (Contd.)
As at 31st December, 2012 As at 31st December, 2011
Number of
Shares
Rupees
in lakhs
Number of
Shares
Rupees
in lakhs
(a) Reconciliation of the number of shares .. ..
Balance at the beginning of the year .. .. 84,703,017 84,70.30 84,703,017 84,70.30
Issued during the year.. .. .. .. — — — —
Balance at the end of the year.. .. .. 84,703,017 84,70.30 84,703,017 84,70.30
(b) Rights, preferences and restrictions attached to equity shares:
The Company has one class of equity shares having a par value of Rs. 10 per share. Each shareholder is eligible for one vote per
share held. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual
General Meeting, except in case of interim dividend. In the event of liquidation, the equity shareholders are eligible to receive the
remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding.
(c) Shares held by subsidiaries of ultimate holding company in aggregate
Number of
Shares
Rupees
in lakhs
Number of
Shares
Rupees
in lakhs
Equity shares of Rs. 10 each (representing 50.67%
of total shareholding) .. .. .. .. 42,917,488 42,91.75 42,917,488 42,91.75
(d) Details of equity shares held by shareholders holding more than 5% shares of the aggregate shares in the Company:
Number of
Shares
%
Shareholding
Number of
Shares
%
Shareholding
Glaxo Group Limited, U.K .. .. .. 30,485,250 35.99% 30,485,250 35.99%
Eskaylab Limited, U.K .. .. .. 5,880,000 6.94% 5,880,000 6.94%
Life Insurance Corporation of India .. .. 4,822,848 5.69% 4,822,669 5.69%
3 RESERVES AND SURPLUS
Rupees in lakhs
As at
31st December
2011
Additions Deductions As at
31st December
2012
Capital Reserve .. .. .. 1,70.97 — — (b) 1,70.97
Capital Redemption Reserve.. .. 2,62.00 — — (c) 2,62.00
General Reserve .. .. .. 706,98.66 (a) 57,72.59 — 764,71.25
711,31.63 57,72.59 769,04.22
Surplus in Statement of Profit and Loss 1139,67.91 561,88.04 (548,47.34) 1153,08.61
Balance as at the beginning of the year 1139,67.91
ProfitfortheyearasperStatementofProfit
and Loss .. .. .. 561,88.04
Less : Appropriations :
Proposed Dividend .. .. (423,51.50)
Tax on distributed profit .. (67,23.25)
Transfer to General Reserve .. (57,72.59)
Balance as at the end of the year .. 1153,08.61
TOTAL .. 1850,99.54 619,60.63 (548,47.34) 1922,12.83
(a) Transfer from Surplus in Statement of Profit and Loss.
(b) Includes Central Government subsidy Rs. 15.00 lakhs and capital profit on reissue of shares forfeited of erstwhile Burroughs
Wellcome (India) Limited Rs. 0.51 lakhs.
(c) Includes Rs. 2,61.95 lakhs on account of buy back of equity shares.
Notes to the Consolidated Financial Statements for the year ended 31st December, 2012 — continued